Copyright Reports & Markets. All rights reserved.

Global Varicella Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Varicella Vaccine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Injection
      • 1.2.2 Freeze-dried powder
    • 1.3 Market Analysis by Applications
      • 1.3.1 Kids Injection
      • 1.3.2 Adults Injection
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Merck
      • 2.1.1 Business Overview
      • 2.1.2 Varicella Vaccine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Varicella Vaccine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Shanghai Institute
      • 2.3.1 Business Overview
      • 2.3.2 Varicella Vaccine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Shanghai Institute Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 BCHT
      • 2.4.1 Business Overview
      • 2.4.2 Varicella Vaccine Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 BCHT Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Changsheng
      • 2.5.1 Business Overview
      • 2.5.2 Varicella Vaccine Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Changsheng Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Keygen
      • 2.6.1 Business Overview
      • 2.6.2 Varicella Vaccine Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Keygen Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Green Cross
      • 2.7.1 Business Overview
      • 2.7.2 Varicella Vaccine Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Green Cross Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Biken
      • 2.8.1 Business Overview
      • 2.8.2 Varicella Vaccine Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Biken Varicella Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Varicella Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Varicella Vaccine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Varicella Vaccine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Varicella Vaccine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Varicella Vaccine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Varicella Vaccine Market Analysis by Regions

    • 4.1 Global Varicella Vaccine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Varicella Vaccine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Varicella Vaccine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 4.5 South America Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Varicella Vaccine Sales and Growth Rate (2014-2019)

    5 North America Varicella Vaccine by Country

    • 5.1 North America Varicella Vaccine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Varicella Vaccine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Varicella Vaccine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Varicella Vaccine Sales and Growth Rate (2014-2019)

    6 Europe Varicella Vaccine by Country

    • 6.1 Europe Varicella Vaccine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Varicella Vaccine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Varicella Vaccine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 6.3 UK Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 6.4 France Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Varicella Vaccine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Varicella Vaccine by Country

    • 7.1 Asia-Pacific Varicella Vaccine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Varicella Vaccine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Varicella Vaccine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 7.5 India Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Varicella Vaccine Sales and Growth Rate (2014-2019)

    8 South America Varicella Vaccine by Country

    • 8.1 South America Varicella Vaccine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Varicella Vaccine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Varicella Vaccine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Varicella Vaccine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Varicella Vaccine by Countries

    • 9.1 Middle East and Africa Varicella Vaccine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Varicella Vaccine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Varicella Vaccine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Varicella Vaccine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Varicella Vaccine Sales and Growth Rate (2014-2019)

    10 Global Varicella Vaccine Market Segment by Type

    • 10.1 Global Varicella Vaccine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Varicella Vaccine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Varicella Vaccine Revenue and Market Share by Type (2014-2019)
    • 10.2 Injection Sales Growth and Price
      • 10.2.1 Global Injection Sales Growth (2014-2019)
      • 10.2.2 Global Injection Price (2014-2019)
    • 10.3 Freeze-dried powder Sales Growth and Price
      • 10.3.1 Global Freeze-dried powder Sales Growth (2014-2019)
      • 10.3.2 Global Freeze-dried powder Price (2014-2019)

    11 Global Varicella Vaccine Market Segment by Application

    • 11.1 Global Varicella Vaccine Sales Market Share by Application (2014-2019)
    • 11.2 Kids Injection Sales Growth (2014-2019)
    • 11.3 Adults Injection Sales Growth (2014-2019)

    12 Varicella Vaccine Market Forecast (2019-2024)

    • 12.1 Global Varicella Vaccine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Varicella Vaccine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Varicella Vaccine Market Forecast (2019-2024)
      • 12.2.2 Europe Varicella Vaccine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Varicella Vaccine Market Forecast (2019-2024)
      • 12.2.4 South America Varicella Vaccine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Varicella Vaccine Market Forecast (2019-2024)
    • 12.3 Varicella Vaccine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Varicella Vaccine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Varicella Vaccine Market Share Forecast by Type (2019-2024)
    • 12.4 Varicella Vaccine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Varicella Vaccine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Varicella Vaccine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

      Scope of the Report:
      As for the global varicella vaccine industry, the industry structure is relatively concentrated. The 72.50% of market share in production is grasped by the top 5 manufacturers. The top three manufacturers are Merck, GSK and Shanghai Institute, which are close to 52 percent totally. The United States giant Merck, which has 30.40% market share in 2015, is the leader in the varicella vaccine industry. The manufacturers following Merck are GSK and Shanghai Institute, which respectively has 10.04% and 11.60% market share globally. The Shanghai Institute is the leader of China varicella vaccine industry.
      The downstream industries of varicella vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of varicella vaccine will be obvious. In the foreseeable future, the varicella vaccine products will show an optimistic upward trend.
      The growth rate in developed regions such as US and Europe is not very fast because they have higher product coverage. And the number of neonatal in their countries is decreasing. So the investors should pay more attention on developing countries such as south Asia, Latin America and Middle-east.
      The worldwide market for Varicella Vaccine is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 4830 million US$ in 2024, from 3050 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Varicella Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Merck
      GSK
      Shanghai Institute
      BCHT
      Changsheng
      Keygen
      Green Cross
      Biken

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Injection
      Freeze-dried powder

      Market Segment by Applications, can be divided into
      Kids Injection
      Adults Injection

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Varicella Vaccine product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Varicella Vaccine, with price, sales, revenue and global market share of Varicella Vaccine in 2017 and 2018.
      Chapter 3, the Varicella Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Varicella Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Varicella Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Varicella Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now